
Defensible values for the assets you cannot tag — purchase price allocations, FRS 102 Section 18 amortisation support and Section 27 impairment testing inputs, built from your own financial data.
For many UK businesses the most valuable assets never appear on a verification walkround: the brand customers choose, the developed technology competitors cannot copy, the contracted customer relationships, the patents, licences and data. These assets are bought, sold, licensed, impaired and litigated over — and at each of those moments someone has to put a defensible number on something that cannot be weighed, scanned or photographed. Get the number wrong and the consequences are concrete: an overstated goodwill balance that triggers an impairment, an amortisation life that fails to survive audit, a royalty rate that hands value to a counterparty, or a transaction price that cannot be supported when it is challenged.
CPCON’s valuation practice covers that intangible layer with the same evidence-first discipline we apply to physical estates across 30+ years and 4,500+ projects. Methodology follows the recognised income, market and cost approaches used in international valuation practice; models are built from your actual financial data rather than templated multiples; and every assumption — royalty rate, discount rate, attrition curve, tax amortisation benefit — is documented so the report stands up to the people who will test it: auditors, HMRC, counterparties and courts. This page sets out the asset types we value, the methods we use, how the FRS 102 mechanics work, and where an intangible valuation fits alongside the physical and logical asset work that surrounds it.
After an acquisition, the price paid is allocated to identifiable intangibles — brands, technology, customer relationships — with the residue to goodwill, setting future amortisation and impairment exposure.
Useful-life evidence for FRS 102 s.18 amortisation, fair value inputs, and recoverable-amount support for s.27 impairment reviews of goodwill and intangibles.
Licensing and royalty-rate setting, franchising, brand sales, transfer pricing and IP-backed financing — values built on relief-from-royalty and excess-earnings evidence.
Shareholder exits, IP infringement quantum, warranty claims and restructuring scenarios where an independent, documented intangible value changes the negotiation.
“Intangibles” is a single line on the balance sheet but a wide population of different assets underneath, each with its own value driver and its own preferred method. The first task in any engagement — and the one most commonly done badly — is identification: separating out everything that can be recognised in its own right before anything is swept into goodwill. The categories below are the ones we see most often in UK engagements.
| Asset type | What it is | Typical method |
|---|---|---|
| Brands & trade marks | Name recognition, reputation and the pricing power they confer; registered marks, trade dress and brand architecture | Relief-from-royalty; sometimes multi-period excess earnings where the brand is the primary earnings driver |
| Patents & technology | Granted patents, patent applications, proprietary processes and unpatented know-how with a defined economic life | Relief-from-royalty or excess earnings; remaining legal and economic life is a critical input |
| Developed & acquired software | Internally developed platforms, acquired code bases and the configured systems a business runs on | Cost to recreate (replacement cost) or relief-from-royalty where the software is licensable |
| Customer relationships & contracts | The recurring value of an established customer base, order backlog and contractual relationships | Multi-period excess earnings, driven by an attrition (churn) curve and contributory asset charges |
| Non-compete agreements | The protective value of a vendor or key person agreeing not to compete for a defined period | With-and-without method — modelling cash flows with the agreement against the scenario it prevents |
| Goodwill | The residual value in a business combination not attributable to identifiable assets and liabilities | Calculated as a residual after all identifiable intangibles and tangibles are valued; amortised under FRS 102 |
A brand is the accumulated reputation, recognition and customer preference attached to a name, mark or get-up — and the pricing power and demand it generates. The dominant approach is relief-from-royalty: if you did not own the brand you would have to license it, so its value is the present value of the royalties you are relieved from paying. The hard part is the royalty rate. We support it with licensing databases, observed third-party agreements in the sector, and a profit-split sense-check that the implied royalty leaves the licensee a reasonable return. Where the brand is genuinely the engine of the whole business — a consumer-products company built around one name — a multi-period excess earnings model can be more appropriate, with the brand carrying the residual earnings after every other asset is charged for the return it requires.
Technology assets span granted patents, patent applications, proprietary processes, unpatented know-how, and the developed and acquired software a business runs on. The defining input is the remaining economic life: a patent has a legal expiry, but the economic life can be shorter where the technology is being superseded. Relief-from-royalty fits licensable technology; excess-earnings fits technology that is the primary driver of a product’s cash flows; and a replacement-cost approach fits internally built software where the most reliable evidence is what it would cost to recreate the code base and configuration today. For acquired software in a PPA, separating the asset from the assembled workforce that maintains it — and from goodwill — is a common point of audit challenge that careful documentation resolves.
The value of an established customer base is rarely contractual in full, but it is real: existing customers cost less to retain than new ones cost to win, and they generate predictable recurring margin. The standard method is multi-period excess earnings, modelling the cash flows from the existing customer base, applying an attrition curve that runs the base off over time, and deducting contributory asset charges — a fair return for the working capital, fixed assets, workforce and brand that the relationships also rely on — so the value left is the earnings genuinely attributable to the customer asset alone. Order backlog and specific contracts are usually valued separately over their own shorter horizon. Getting the churn data right is the single biggest driver of the answer, which is why we ask for it early.
A non-compete agreement has value because it prevents a vendor or key individual from competing and eroding the business that was bought. The with-and-without method captures exactly that: model the business cash flows with the agreement in place, model them again without it (factoring the probability the person would and could compete, and the damage they would do), and the difference, discounted, is the value of the protection. The agreement’s defined term bounds the horizon, and the probability assumptions are documented so the auditor can test the judgement rather than accept an assertion.
Goodwill is not valued directly; it is what remains of the consideration once every identifiable tangible and intangible asset has been recognised and measured at fair value. That makes goodwill a function of the rigour applied everywhere else: under-identify the intangibles and goodwill is overstated, the wrong assets sit on the balance sheet, and the amortisation and impairment profile is distorted for years. Because we value the identifiable intangibles properly and reconcile the tangible side to verified physical assets, the goodwill figure we arrive at is a genuine residual, not a dumping ground for everything that was too difficult to value.
Valuation practice recognises three approaches — income, market and cost — and within them a handful of specific methods. There is no single “right” method; the discipline is matching the method to the asset and to the quality of evidence available, and cross-checking one approach against another where the data allows.
| Method | Approach | Best suited to |
|---|---|---|
| Relief-from-royalty | Income | Brands, trade marks, patents, licensable technology and software — assets you could otherwise license in |
| Multi-period excess earnings (MEEM) | Income | The single asset that drives the business cash flows — typically customer relationships or core technology |
| With-and-without | Income | Non-compete agreements and other protective assets whose value is the loss they prevent |
| Replacement / reproduction cost | Cost | Assembled workforce, internally built software and assets with no reliable income or market evidence |
| Market (comparable transactions) | Market | Where genuinely comparable arm’s-length licence or sale evidence for similar assets exists |
For UK GAAP reporters the accounting for intangibles is governed by FRS 102 Section 18 (Intangible Assets other than Goodwill) and Section 19 (Business Combinations and Goodwill), with impairment under Section 27. The headlines that drive valuation work:
Two intangible valuations of the same asset can differ by a wide margin, and the difference almost never comes from the choice of method — it comes from a small number of inputs. Knowing which ones matter, and documenting them properly, is what separates a number that survives challenge from one that does not.
Acquired intangibles and goodwill do not just sit on the balance sheet quietly amortising — they have to be tested when something suggests they may be worth less than their carrying amount. FRS 102 Section 27 sets the framework, and the valuation inputs it demands are exactly what this practice produces.
Because impairment of an intangible or a CGU often coincides with questions about the physical assets in the same unit, an impairment review is another point where doing the tangible and intangible work together — on one reconciled evidence base — produces a cleaner, faster answer than two disconnected exercises.
A purchase price allocation is where intangible valuation, tangible valuation and accounting meet, and it is the engagement type that most rewards a single firm doing all three. The sequence we follow:
Long before the PPA, intangibles matter in diligence. A buyer needs to know whether the IP it is paying for is actually owned and properly registered, whether key contracts and customer relationships transfer on a change of control, whether brand rights are clear in every market that matters, and whether the technology depends on people who could walk. A valuation-led view of the intangibles sharpens all of that: it tells the buyer where the value really sits, which of those assets are fragile, and what a defensible allocation will look like after completion — so the price, the warranties and the post-deal accounting are aligned from the start rather than reconciled in a scramble at year-end.
An intangible valuation is only as useful as the report that carries it, and the report’s job is to let an informed reader test the conclusion rather than take it on trust. Whatever the purpose — financial reporting, transaction or dispute — the file we deliver is built to be scrutinised:
That discipline is the same one CPCON applies to physical estates: document the evidence, show the working, and prepare every figure to be tested by the people who have most reason to challenge it.
Intangible values rarely live alone: a PPA allocates one price across plant, property, stock and brands; an impairment review of a cash-generating unit spans every asset in it. Because CPCON also delivers plant & machinery and business valuations and physical verification, the tangible side of the allocation rests on verified, existing assets rather than book values taken on trust. Where assets need a permanent identity for future counts and movement control, asset tagging closes the loop, and where the population also includes stock, independent stocktaking services put the same evidence discipline under inventory. It is one engagement, one consistent evidence base, reconciled to the fixed asset register your auditor already samples — and underpinned by 30+ years and 4,500+ projects reconciling the physical, the logical and the accounting view of what an organisation owns.
Under FRS 102, no — internally generated brands, mastheads, customer lists, publishing titles and similar items cannot be recognised as assets; recognition essentially follows acquisition, either separately or in a business combination. That does not make valuing them pointless: brand and IP valuations for internally generated assets are commissioned for licensing, franchising, transactions, disputes, transfer pricing and strategic decisions — the value is real even when the accounting says it stays off the books.
Intangible assets under FRS 102 are treated as having finite useful lives and amortised over them on a systematic basis. Where management cannot make a reliable estimate of the useful life, FRS 102 caps the period used at 10 years. Setting a defensible life — backed by contract terms, patent expiry, technology cycles, customer churn data or market evidence — is one of the most common reasons a valuation specialist is brought in, because the life drives the annual amortisation charge and the impairment exposure.
The standard income-approach toolkit, chosen to fit the asset: relief-from-royalty (what would it cost to license the brand or technology you already own), multi-period excess earnings for the asset that drives the business cash flows, with-and-without comparisons for assets such as non-compete agreements, and cost approaches where reproduction or replacement cost is genuinely the value driver. Every method is documented with its inputs — royalty rate, discount rate, attrition curve, tax amortisation benefit — so your auditor can challenge the model, not guess at it.
An identifiable intangible can be separated and sold, licensed or transferred on its own, or it arises from contractual or legal rights — brands, patents, software, customer contracts, non-compete agreements. Goodwill is the residual: the part of the price paid in a business combination that cannot be attributed to identifiable assets and liabilities. In a purchase price allocation the identifiable intangibles are valued first, and only what is left over is goodwill — so under-identifying intangibles inflates goodwill and changes the future amortisation profile.
FRS 102 treats goodwill as having a finite life and amortises it — there is no indefinite-life, annual-impairment-only treatment as under full IFRS. Where the life cannot be estimated reliably the same 10-year cap applies. Goodwill and other intangibles are then tested for impairment under Section 27 when indicators exist, by comparing carrying amount to recoverable amount (the higher of value in use and fair value less costs to sell). Both the amortisation life and the recoverable-amount estimate need defensible valuation evidence.
Yes — PPA is one of the core uses of this service. After a business combination the consideration is allocated across the acquired tangible assets, identifiable intangibles and goodwill at fair value as at the acquisition date. Because CPCON also verifies and values the tangible side — plant, machinery, fixtures, stock — the whole allocation rests on one consistent, evidenced base rather than book values taken on trust, which is exactly what acquirers and their auditors want to see.
They are frequently used for it. Royalty rates for intra-group licensing of brands and technology, the value of IP migrated between entities, and the arm’s-length pricing of intangible transfers all rest on the same relief-from-royalty and excess-earnings evidence. For UK corporation tax, relief on acquired intangibles generally runs through the intangible fixed assets regime by reference to accounting amortisation — so the valuation, the amortisation life and the tax position are linked, and your tax adviser will want the asset-level detail a proper valuation file carries.
The methodology is the same, but the reporting standard is higher because the number will be tested adversarially. We document every input and assumption, state the basis of value clearly, and prepare the file so it survives cross-examination, expert challenge or HMRC enquiry. Shareholder exits, warranty and indemnity claims, IP infringement quantum and matrimonial or partnership disputes all benefit from an independent, fully evidenced intangible value rather than a negotiating assertion.
Typically: management accounts and forecasts, revenue split by brand or product where it exists, the IP schedule (registrations, patents, domains, licences and key contracts), customer and churn data for relationship assets, the acquisition agreement and any prior valuations or PPA reports. A scoping call establishes what actually exists — engagements are sized around real data availability, not an idealised checklist — and we tell you early where a method will be constrained by missing data so there are no surprises at the report stage.
Tell us about your sites and asset volumes — we respond within one business day with a scoped proposal.
Request a Proposal